BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24369055)

  • 1. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
    Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
    Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47.
    Lee YJ; Nam EJ; Kim S; Kim YT; Itkin-Ansari P; Kim SW
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTG16 regulates colonic epithelial differentiation, colitis, and tumorigenesis by repressing E protein transcription factors.
    Brown RE; Jacobse J; Anant SA; Blunt KM; Chen B; Vega PN; Jones CT; Pilat JM; Revetta F; Gorby AH; Stengel KR; Choksi YA; Palin K; Piazuelo MB; Washington MK; Lau KS; Goettel JA; Hiebert SW; Short SP; Williams CS
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35503250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumol inhibits the viability and invasion of colorectal cancer cells via miR-30a-5p and Hippo signaling pathway.
    Yu D; Liu H; Qin J; Huangfu M; Guan X; Li X; Zhou L; Dou T; Liu Y; Wang L; Fu M; Wang J; Chen X
    Oncol Lett; 2021 Apr; 21(4):299. PubMed ID: 33732375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
    Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
    J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual roles of yes-associated protein (YAP) in colorectal cancer.
    Ou C; Sun Z; Li S; Li G; Li X; Ma J
    Oncotarget; 2017 Sep; 8(43):75727-75741. PubMed ID: 29088905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer.
    Jiao S; Li C; Hao Q; Miao H; Zhang L; Li L; Zhou Z
    Nat Commun; 2017 Jan; 8():14058. PubMed ID: 28051067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
    Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
    Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.
    Kang W; Cheng AS; Yu J; To KF
    World J Gastroenterol; 2016 Jan; 22(3):1279-88. PubMed ID: 26811664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-sensing GPCR-YAP Signalling Promotes Cell Proliferation and Survival.
    Zhu H; Cheng X; Niu X; Zhang Y; Guan J; Liu X; Tao S; Wang Y; Zhang C
    Int J Biol Sci; 2015; 11(10):1181-9. PubMed ID: 26327812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
    Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
    Li C; Cai S; Wang X; Jiang Z
    PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2A suppresses invasion and migration by targeting YAP in colorectal cancer cells.
    Zhao H; Huang A; Li P; Quan Y; Feng B; Chen X; Mao Z; Zhu Z; Zheng M
    J Transl Med; 2013 Dec; 11():317. PubMed ID: 24369055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway.
    Zhao H; Zhao C; Li H; Zhang D; Liu G
    J Exp Clin Cancer Res; 2019 Jun; 38(1):276. PubMed ID: 31234887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
    Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
    Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma.
    Wang S; Li H; Wang G; Zhang T; Fu B; Ma M; Quan Z; Chen G
    Clin Transl Oncol; 2016 Feb; 18(2):172-7. PubMed ID: 26254048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.